As of 2025-12-07, the Intrinsic Value of PAVmed Inc (PAVM) is 629.25 USD. This PAVM valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.33 USD, the upside of PAVmed Inc is 191,162.80%.
The range of the Intrinsic Value is 499.48 - 850.83 USD
Based on its market price of 0.33 USD and our intrinsic valuation, PAVmed Inc (PAVM) is undervalued by 191,162.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 499.48 - 850.83 | 629.25 | 191162.8% |
| DCF (Growth 10y) | 626.79 - 1,039.08 | 779.58 | 236854.5% |
| DCF (EBITDA 5y) | 889.23 - 1,080.85 | 982.35 | 298487.8% |
| DCF (EBITDA 10y) | 969.54 - 1,233.75 | 1,094.70 | 332635.5% |
| Fair Value | 0.56 - 0.56 | 0.56 | 70.17% |
| P/E | 0.71 - 5.18 | 2.69 | 717.9% |
| EV/EBITDA | (3.03) - 1.18 | (1.09) | -430.2% |
| EPV | (29.22) - (39.15) | (34.19) | -10491.7% |
| DDM - Stable | 0.54 - 1.49 | 1.01 | 208.2% |
| DDM - Multi | 184.21 - 444.16 | 265.66 | 80647.6% |
| Market Cap (mil) | 9.09 |
| Beta | 1.70 |
| Outstanding shares (mil) | 27.64 |
| Enterprise Value (mil) | 12.63 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.17% |
| Cost of Debt | 5.00% |
| WACC | 5.46% |